The primary randomised controlled trial was published in The Lancet Respiratory Medicine. Routine prophylactic azithromycin did not improve survival without physiologically defined moderate or severe chronic lung disease.
AZTEC news
The primary randomised controlled trial was published in The Lancet Respiratory Medicine. Routine prophylactic azithromycin did not improve survival without physiologically defined moderate or severe chronic lung disease.